These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26722517)
1. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance. Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517 [TBL] [Abstract][Full Text] [Related]
2. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781 [TBL] [Abstract][Full Text] [Related]
3. Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence. Ongaratti BR; Silva CB; Trott G; Haag T; Leães CG; Ferreira NP; Oliveira MC; Pereira-Lima JF Braz J Med Biol Res; 2016; 49(4):e5125. PubMed ID: 27007654 [TBL] [Abstract][Full Text] [Related]
4. Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence. Trott G; Pereira-Lima JF; Leães CG; Ferreira NP; Barbosa-Coutinho LM; Oliveira MC Braz J Med Biol Res; 2015 May; 48(5):415-9. PubMed ID: 25742638 [TBL] [Abstract][Full Text] [Related]
5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study. Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338 [TBL] [Abstract][Full Text] [Related]
7. Expression of somatostatin receptors in canine and feline meningioma. Immler M; Wolfram M; Oevermann A; Walter I; Wolfesberger B; Tichy A; Gradner G Vet Med Sci; 2024 Jul; 10(4):e1537. PubMed ID: 39011594 [TBL] [Abstract][Full Text] [Related]
8. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes. Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
10. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas. Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945 [TBL] [Abstract][Full Text] [Related]
11. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density? Barresi V; Alafaci C; Salpietro F; Tuccari G Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806 [TBL] [Abstract][Full Text] [Related]
13. Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas. Tseng KY; Chung MH; Sytwu HK; Lee HM; Chen KY; Chang C; Lin CK; Yen CH; Chen JH; Lin GJ; Ma HI; Yeh YS; Ju DT; Liu MY; Hueng DY J Neurooncol; 2010 Nov; 100(2):217-23. PubMed ID: 20428925 [TBL] [Abstract][Full Text] [Related]
15. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of STMN1 is associated with the prognosis of meningioma patients. Wang H; Li W; Wang G; Zhang S; Bie L Neurosci Lett; 2017 Jul; 654():1-5. PubMed ID: 28625575 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521 [TBL] [Abstract][Full Text] [Related]
19. A study of UbcH10 expression and its association with recurrence of meningiomas. Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464 [TBL] [Abstract][Full Text] [Related]
20. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma? Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]